1. Academic Validation
  2. CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways

CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways

  • Cytokine. 2011 Dec;56(3):699-707. doi: 10.1016/j.cyto.2011.09.007.
Jette Lindorff Riis 1 Claus Johansen Christian Vestergaard Kristian Otkjaer Knud Kragballe Lars Iversen
Affiliations

Affiliation

  • 1 Department of Dermatology, Aarhus Sygehus, Aarhus University Hospital, Aarhus C, Denmark. jette.lindorff.riis@ki.au.dk
Abstract

The skin-specific chemokine CCL27 is believed to play a pivotal role in establishing the inflammatory infiltrate characteristic for common inflammatory skin diseases. Through binding to the Chemokine Receptor 10 (CCR10), CCL27 mediates inflammation by promoting lymphocyte migration into the skin. Little is known about the regulation of CCL27 gene expression. The purpose of our study was to investigate the regulation of the IL-1β-induced CCL27 gene expression in normal human keratinocytes (NHEK). Preincubation of NHEK with the inhibitory κB (IκB) kinase (IKK) inhibitor, SC-514, or the p38 mitogen-activated protein kinase (MAPK) inhibitor, SB202190, revealed a profound reduction in both CCL27 mRNA and CCL27 protein expression indicating the significance of these pathways in the regulation of CCL27 expression. Furthermore, the impact of inhibitors of mitogen- and stress-activated kinase 1 (MSK1) or the mitogen-activated protein kinase-interacting kinases (Mnk1+2), downstream kinases of p38 MAPK, on IL-1β-induced CCL27 expression in NHEK were investigated. We identified seven NF-κB binding elements upstream from the CCL27 gene start codon using electrophoretic mobility shift assay (EMSA). Supershift analyses demonstrated the involvement of the p50/p65 NF-κB heterodimer. We conclude that IL-1β-induced CCL27 gene expression in NHEK is regulated through the p38 MAPK/MSK1/Mnk1+2 as well as the IKKβ/NF-κB signalling pathways.

Figures
Products